- Home
- PMVP vs PYPD Comparison
PMVP vs PYPD Comparison
Compare PMVP & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- PYPD
- Stock Information
- Founded
- PMVP 2013
- PYPD 2008
- Country
- PMVP United States
- PYPD Israel
- Employees
- PMVP N/A
- PYPD N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- PYPD Medical/Dental Instruments
- Sector
- PMVP Health Care
- PYPD Health Care
- Exchange
- PMVP Nasdaq
- PYPD Nasdaq
- Market Cap
- PMVP 68.9M
- PYPD 57.8M
- IPO Year
- PMVP 2020
- PYPD 2020
- Fundamental
- Price
- PMVP $1.33
- PYPD $3.75
- Analyst Decision
- PMVP Strong Buy
- PYPD Strong Buy
- Analyst Count
- PMVP 1
- PYPD 5
- Target Price
- PMVP $5.00
- PYPD $12.00
- AVG Volume (30 Days)
- PMVP 259.0K
- PYPD 67.5K
- Earning Date
- PMVP 11-12-2025
- PYPD 11-12-2025
- Dividend Yield
- PMVP N/A
- PYPD N/A
- EPS Growth
- PMVP N/A
- PYPD N/A
- EPS
- PMVP N/A
- PYPD N/A
- Revenue
- PMVP N/A
- PYPD N/A
- Revenue This Year
- PMVP N/A
- PYPD N/A
- Revenue Next Year
- PMVP N/A
- PYPD N/A
- P/E Ratio
- PMVP N/A
- PYPD N/A
- Revenue Growth
- PMVP N/A
- PYPD N/A
- 52 Week Low
- PMVP $0.81
- PYPD $2.30
- 52 Week High
- PMVP $1.84
- PYPD $3.93
- Technical
- Relative Strength Index (RSI)
- PMVP 47.49
- PYPD 61.23
- Support Level
- PMVP $1.30
- PYPD $3.50
- Resistance Level
- PMVP $1.44
- PYPD $3.69
- Average True Range (ATR)
- PMVP 0.08
- PYPD 0.14
- MACD
- PMVP -0.00
- PYPD -0.01
- Stochastic Oscillator
- PMVP 50.00
- PYPD 83.82
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.